138 related articles for article (PubMed ID: 19319668)
1. High dose Losartan and ACE gene polymorphism in IgA nephritis.
Woo KT; Chan CM; Choong HL; Tan HK; Foo M; Lee EJ; Tan CC; Lee GS; Tan SH; Vathsala A; Lim CH; Chiang GS; Fook-Chong S; Yi Z; Tan HB; Wong KS
Genomic Med; 2008 Dec; 2(3-4):83-91. PubMed ID: 19319668
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of high-dose losartan in IgA nephritis.
Woo KT; Chan CM; Tan HK; Choong HL; Foo M; Vathsala A; Lee EJ; Tan CC; Lee GS; Tan SH; Lim CH; Chiang GS; Fook-Chong S; Wong SK
Clin Nephrol; 2009 Jun; 71(6):617-24. PubMed ID: 19473629
[TBL] [Abstract][Full Text] [Related]
3. Disease progression, response to ACEI/ATRA therapy and influence of ACE gene in IgA nephritis.
Woo KT; Lau YK; Zhao Y; Liu FE; Tan HB; Tan EK; Stephanie FC; Chan CM; Wong KS
Cell Mol Immunol; 2007 Jun; 4(3):227-32. PubMed ID: 17601378
[TBL] [Abstract][Full Text] [Related]
4. Proteinuria and angiotensin converting enzyme (ACE) gene polymorphism.
Woo KT; Lau YK
Ann Acad Med Singap; 2000 May; 29(3):383-7. PubMed ID: 10976394
[TBL] [Abstract][Full Text] [Related]
5. Additive antiproteinuric effect of combined ACE inhibition and angiotensin II receptor blockade.
Ferrari P; Marti HP; Pfister M; Frey FJ
J Hypertens; 2002 Jan; 20(1):125-30. PubMed ID: 11791035
[TBL] [Abstract][Full Text] [Related]
6. Diuretic uptitration with half dose combined ACEI + ARB better decreases proteinuria than combined ACEI + ARB uptitration.
Esnault VL; Ekhlas A; Nguyen JM; Moranne O
Nephrol Dial Transplant; 2010 Jul; 25(7):2218-24. PubMed ID: 20106824
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibitor versus angiotensin 2 receptor antagonist therapy and the influence of angiotensin-converting enzyme gene polymorphism in IgA nephritis.
Woo KT; Lau YK; Chan CM; Wong KS
Ann Acad Med Singap; 2008 May; 37(5):372-6. PubMed ID: 18536822
[TBL] [Abstract][Full Text] [Related]
8. ACEI/ARB therapy for IgA nephropathy: a meta analysis of randomised controlled trials.
Cheng J; Zhang W; Zhang XH; He Q; Tao XJ; Chen JH
Int J Clin Pract; 2009 Jun; 63(6):880-8. PubMed ID: 19490198
[TBL] [Abstract][Full Text] [Related]
9. Treatment with low-dose angiotensin-converting enzyme inhibitor (ACEI) plus angiotensin II receptor blocker (ARB) in pediatric patients with IgA nephropathy.
Yang Y; Ohta K; Shimizu M; Nakai A; Kasahara Y; Yachie A; Koizumi S
Clin Nephrol; 2005 Jul; 64(1):35-40. PubMed ID: 16047643
[TBL] [Abstract][Full Text] [Related]
10. ACEI/ATRA therapy decreases proteinuria by improving glomerular permselectivity in IgA nephritis.
Woo KT; Lau YK; Wong KS; Chiang GS
Kidney Int; 2000 Dec; 58(6):2485-91. PubMed ID: 11115082
[TBL] [Abstract][Full Text] [Related]
11. Distinct time courses of renal protective action of angiotensin receptor antagonists and ACE inhibitors in chronic renal disease.
Matsuda H; Hayashi K; Saruta T
J Hum Hypertens; 2003 Apr; 17(4):271-6. PubMed ID: 12692572
[TBL] [Abstract][Full Text] [Related]
12. Long-term treatment by ACE inhibitors and angiotensin receptor blockers in children with Alport syndrome.
Zhang Y; Wang F; Ding J; Zhang H; Liu X; Wang S; Xiao H; Yao Y; Liu J; Zhong X; Guan N; Su B; Wu G; Yu L
Pediatr Nephrol; 2016 Jan; 31(1):67-72. PubMed ID: 26248473
[TBL] [Abstract][Full Text] [Related]
13. Combined therapy of cilazapril and losartan has no additive effects in ameliorating adriamycin-induced glomerulopathy.
Kim HJ; Ryu JH; Han SW; Park IK; Paik SS; Park MH; Paik DJ; Chung HS; Kim SW; Lee JU
Nephron Physiol; 2004; 97(4):p58-65. PubMed ID: 15331931
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of the efficacy of angiotensin II receptor blockers for uric acid level change in asymptomatic hyperuricaemia.
Kim HS; Kim H; Lee SH; Kim JH
J Clin Pharm Ther; 2020 Dec; 45(6):1264-1270. PubMed ID: 32737930
[TBL] [Abstract][Full Text] [Related]
15. Deletion polymorphism of the angiotensin converting enzyme gene predicts persistent proteinuria in Henoch-Schönlein purpura nephritis.
Yoshioka T; Xu YX; Yoshida H; Shiraga H; Muraki T; Ito K
Arch Dis Child; 1998 Nov; 79(5):394-9. PubMed ID: 10193250
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin converting enzyme insertion/deletion polymorphism and short-term renal response to ACE inhibition: role of sodium status.
van der Kleij FG; Schmidt A; Navis GJ; Haas M; Yilmaz N; de Jong PE; Mayer G; de Zeeuw D
Kidney Int Suppl; 1997 Dec; 63():S23-6. PubMed ID: 9407415
[TBL] [Abstract][Full Text] [Related]
17. The effect of angiotensin receptor blockade ARB on the regression of left ventricular hypertrophy in hemodialysis patients: comparison between patients with D allele and non-D allele ACE gene polymorphism.
Nakayama M; Nakano H; Tsuboi N; Kurosawa T; Tsuruta Y; Iwasaki Y; Yokoyama K; Hosoya T; Fukagawa M
Clin Nephrol; 2005 Nov; 64(5):358-63. PubMed ID: 16312263
[TBL] [Abstract][Full Text] [Related]
18. Effects of dual blockade of renin-angiotensin system in type 2 diabetes mellitus patients with diabetic nephropathy.
Krairittichai U; Chaisuvannarat V
J Med Assoc Thai; 2009 May; 92(5):611-7. PubMed ID: 19459520
[TBL] [Abstract][Full Text] [Related]
19. Renal Protective Effects of Combination of Diltiazem and ACEI/ARB on the Progression of Diabetic Nephropathy: Randomized Controlled Trial.
Krairittichai U; Sarinnapakorn V; Mahannopkul R; Ainwan P
J Med Assoc Thai; 2017 Feb; 100 Suppl 1():S40-7. PubMed ID: 29927180
[TBL] [Abstract][Full Text] [Related]
20. [Renoprotective effect of triple therapy with low-dose angiotensin receptor blocker, low-dose diuretic and Ca-antagonist in hypertensive type 2 diabetic patients with overt nephropathy].
Kuriyama S; Tomonari H; Ohtsuka Y; Ohkido I; Hosoya T
Nihon Jinzo Gakkai Shi; 2003; 45(4):367-71. PubMed ID: 12806973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
